阿托伐他汀及血管紧张素Ⅱ对人体脂肪组织白细胞介素6及Ⅰ型纤溶酶原激活剂抑制物分泌的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The Effect of Atorvastatin and AngiotensinⅡ on the Release of Interleukin-6 and Type-Ⅰ-Plasminogen-Activator-Inhibitor from Human Adipose Tissue
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 观察不同部位脂肪组织的分泌功能,以及血管紧张素Ⅱ和他汀类药物对脂肪组织分泌白细胞介素6和Ⅰ型纤溶酶原激活剂抑制物的影响。方法 检测体外培养的人内脏及腹部皮下脂肪组织在加用阿托伐他汀及血管紧张素Ⅱ作用前后白细胞介素6和Ⅰ型纤溶酶原激活剂抑制物的分泌水平。结果 内脏脂肪组织分泌白细胞介素6 (16 5 3±339pg/ g组织)高于皮下脂肪组织(116 3±733pg/ g组织,P<0 .0 1) ,内脏脂肪组织分泌Ⅰ型纤溶酶原激活剂抑制物(10 0±30ng/ g组织)也高于皮下脂肪组织(6 8±14ng/ g组织,P<0 .0 1)。内脏及皮下脂肪组织分泌的白细胞介素6与体质指数呈正相关(r分别为0 .85和0 .6 9,P<0 .0 1)。内脏及皮下脂肪组织分泌的Ⅰ型纤溶酶原激活剂抑制物与体质指数呈正相关(r分别为0 .6 3和0 .71,P<0 .0 1)。血管紧张素Ⅱ使内脏及皮下脂肪分泌白细胞介素6分别增加19%和18% ,使内脏及皮下脂肪分泌Ⅰ型纤溶酶原激活剂抑制物分别增加15 %和14 % ;阿托伐他汀使内脏及皮下脂肪分泌白细胞介素6分别减少2 5 %和2 1% ,使内脏及皮下脂肪分泌Ⅰ型纤溶酶原激活剂抑制物分别减少17%和16 %。结论 人体不同部位的脂肪组织分泌炎性细胞因子和纤溶物质存在差异,且与肥胖有关。血管紧张素Ⅱ和阿托伐他汀可刺激和抑制脂肪组织分泌白细胞介素6和Ⅰ型纤溶酶原激活剂抑制物

    Abstract:

    Aim To detect the secretion of different adipose tissue and observe the effect of angiotensin Ⅱ and statin on release of interleukin-6(IL-6) and type-Ⅰ-plasminogen-activator-inhibitor(PAI-1) from human adipose tissue. Methods The human omental and subcutanoems adipose tissues were cultured. The concentration of IL-6 and PAI-1 in media were measured by enzyme-linked immunosorbent assay(ELISA). Results IL-6 released from omental adipose tissue (1 653±339 pg/g tissue) was higher than that from subcutaneous adipose tissue (1 163±733 pg/g tissue, p<0.01), PAI-1 released from omental adipose tissue (100±30 ng/g tissue) is higher than that from subcutaneous adipose tissue (68±14 ng/g tissue, p<0.01) too. IL-6 released from omental and subcutaneous adipose tissue was postively associated with BMI. (r=0.85, 0.69, respectively, both p<0.01). PAI-1 released from omental and subcutaneous adipose tissue is postively associated with BMI (r=0.63, 0.67 respectively, both p<0.01). Angiotensin increased the release of IL-6 from omental and subcutaneous tissue by 19% and 18%, and that of PAI-1 by 15% and 14%, respectively. Atorvastatin suppressed IL-6 release from omental and subtaneouse adipose tissue by 25% and 21%, and suppressed PAI-1 release from omental and subcutaneous adipose tissue by 17% and 16% respectively. Conclusions Adipose tissue can secrete some kinds of cytokine and substances which are associated with obesity. The effect can be stimulated by angiotension and suppressed by atorvastatin.

    参考文献
    相似文献
    引证文献
引用本文

赵水平,王小清,李全忠,唐汉权.阿托伐他汀及血管紧张素Ⅱ对人体脂肪组织白细胞介素6及Ⅰ型纤溶酶原激活剂抑制物分泌的影响[J].中国动脉硬化杂志,2005,13(1):73~75.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2004-02-08
  • 最后修改日期:2004-12-31
  • 录用日期:
  • 在线发布日期: